Clinical Trial Update: Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial assessing Silicon Phthalocyanine 4 with photodynamic therapy in recurrent cutaneous T-cell lymphoma including mycosis fungoides and Sezary syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• Silicon phthalocyanine 4 (silicon phthalocyanine 4)

Snippet

Sponsor: Kevin Cooper MD | Conditions: Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2019-05-16